Global Hemorrhoids Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Treatment Type;
Drugs - Laxatives, NSAIDs, Herbals & Others, Non-Surgical Procedures.By Administration Route;
Oral and Topical.By Distribution Channel;
Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Hemorrhoids Treatment Market (USD Million), 2021 - 2031
In the year 2024, the Global Hemorrhoids Treatment Market was valued at USD 958.65 million. The size of this market is expected to increase to USD 2,166.77 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.4%.
The global hemorrhoids treatment market has witnessed substantial growth in recent years, driven by a combination of factors including increasing prevalence of hemorrhoids, advancements in treatment options, and growing awareness among patients. Hemorrhoids, also known as piles, are a common condition characterized by swollen veins in the rectum or anus, causing discomfort, pain, and sometimes bleeding during bowel movements. The prevalence of hemorrhoids is on the rise globally, attributed to sedentary lifestyles, unhealthy dietary habits, and aging populations. As a result, the demand for effective treatment options has surged, propelling the growth of the hemorrhoids treatment market.
Innovations in medical technology and procedures have revolutionized the management of hemorrhoids, offering patients a range of minimally invasive and surgical options. Traditional treatments such as topical creams and ointments have been supplemented with advanced procedures including rubber band ligation, sclerotherapy, infrared coagulation, and minimally invasive surgeries like hemorrhoidectomy and stapled hemorrhoidopexy. These advancements have not only improved treatment outcomes but have also reduced patient discomfort and recovery times, driving the adoption of these procedures and bolstering market growth.
Increasing healthcare expenditure, particularly in emerging economies, and rising awareness campaigns about the importance of early diagnosis and treatment of hemorrhoids have contributed to the expansion of the global hemorrhoids treatment market. Governments and healthcare organizations are increasingly focusing on promoting preventive measures and ensuring access to affordable treatment options, thereby fueling market growth further. With a growing patient pool seeking relief from the symptoms of hemorrhoids and ongoing efforts to enhance treatment modalities, the hemorrhoids treatment market is poised for continued expansion in the coming years.
Global Hemorrhoids Treatment Market Recent Developments
-
In June 2023, Gero announced that it has entered into a research collaboration with Pfizer to apply Gero's machine-learning technology platform to discover potential therapeutic targets for fibrotic diseases using large-scale human-based data.
-
In June 2023, Novartis announced that it has agreed to acquire Chinook Therapeutics, a Seattle, WA, based clinical-stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney diseases. The agreed deal, subject to customary closing conditions, is fully in line with Novartis' strategy to focus on innovative medicines and will significantly expand its renal portfolio, complementing the existing pipeline.
Segment Analysis
The global hemorrhoids treatment market is witnessing significant growth, driven by factors such as an increase in the prevalence of hemorrhoids worldwide and advancements in treatment options. Hemorrhoids, characterized by swollen veins in the rectum or anus, affect a substantial portion of the population, especially adults. This demographic trend, coupled with lifestyle changes such as sedentary habits and unhealthy diets, fuels the demand for effective treatment solutions.
The market is witnessing a surge in research and development activities aimed at introducing innovative therapies and products. Pharmaceutical companies are investing heavily in developing novel drugs and formulations to address the unmet needs of patients suffering from hemorrhoids. This influx of new treatment options not only broadens the therapeutic landscape but also enhances patient outcomes and experiences.
The growing awareness about hemorrhoids and the availability of various treatment modalities contribute to market expansion. Healthcare providers are increasingly educating patients about the causes, symptoms, and treatment options for hemorrhoids, leading to early diagnosis and intervention. Additionally, technological advancements in diagnostic techniques and treatment procedures facilitate precise diagnosis and targeted therapy, further propelling market growth.
The global hemorrhoids treatment market is witnessing robust growth, driven by factors such as the rising prevalence of hemorrhoids, advancements in treatment options, increased research and development activities, and growing awareness among patients and healthcare providers. As the market continues to evolve, stakeholders are expected to focus on developing innovative therapies and enhancing patient care to meet the growing demand for effective hemorrhoid treatments.
Global Hemorrhoids Treatment Segment Analysis
In this report, the Global Hemorrhoids Treatment Market has been segmented by Treatment Type, Administration Route, Distribution Channel and Geography.
Global Hemorrhoids Treatment Market, Segmentation by Treatment Type
The Global Hemorrhoids Treatment Market has been segmented by Treatment Type into Drugs and Non-Surgical Procedures.
The global hemorrhoids treatment market can be segmented by treatment type into several categories, each catering to specific patient needs. One prominent treatment option is medication, which includes over-the-counter remedies such as creams, ointments, and suppositories designed to alleviate symptoms like itching and pain. These medications often contain ingredients like hydrocortisone or witch hazel, aiming to reduce inflammation and soothe discomfort associated with hemorrhoids.
Another significant treatment approach is minimally invasive procedures, which offer alternatives to traditional surgery for more severe cases. These procedures include rubber band ligation, sclerotherapy, and infrared coagulation, among others. Rubber band ligation involves placing a small rubber band at the base of the hemorrhoid to cut off its blood supply, causing it to shrink and fall off. Sclerotherapy involves injecting a solution into the hemorrhoid to shrink it, while infrared coagulation uses heat to create scar tissue, effectively reducing blood flow to the hemorrhoid.
Surgical interventions represent another category of hemorrhoids treatment, typically reserved for severe cases that don't respond to other methods. Hemorrhoidectomy, the surgical removal of hemorrhoids, may be recommended when other treatments fail to provide relief. This procedure involves cutting out the hemorrhoidal tissue and is usually performed under general anesthesia. While more invasive, surgical options may offer long-term relief for patients with persistent or severe hemorrhoids.
Global Hemorrhoids Treatment Market, Segmentation by Administration Route
The Global Hemorrhoids Treatment Market has been segmented by Administration Route into Oral and Topical.
The global hemorrhoids treatment market, categorized by administration route, exhibits diverse trends and strategies in addressing this common medical condition. One significant route of administration is topical applications. These include creams, ointments, and suppositories designed to alleviate symptoms such as itching, swelling, and pain associated with hemorrhoids. Topical treatments often contain ingredients like hydrocortisone, lidocaine, or witch hazel, providing relief by reducing inflammation and numbing the affected area. This segment of the market is characterized by a wide array of products catering to varying patient preferences and severity of symptoms.
Another prominent administration route in the hemorrhoids treatment market is oral medication. Oral medications typically include non-prescription pain relievers such as ibuprofen or acetaminophen, which help manage discomfort associated with hemorrhoids. Additionally, fiber supplements or stool softeners may be recommended to promote smoother bowel movements and reduce straining during defecation, thus easing symptoms and preventing exacerbation of hemorrhoids. This segment reflects a focus on systemic approaches to managing hemorrhoids, aiming to address underlying causes and improve overall bowel health.
Surgical interventions constitute another essential segment of the hemorrhoids treatment market, particularly for severe or persistent cases. Procedures such as hemorrhoidectomy, rubber band ligation, and sclerotherapy are employed to remove or shrink hemorrhoidal tissue, providing long-term relief from symptoms. Surgical interventions are often considered when conservative measures fail to adequately alleviate discomfort or when complications such as thrombosis or prolapse occur. This segment of the market underscores the importance of specialized medical procedures in addressing hemorrhoids and improving patients' quality of life.
Global Hemorrhoids Treatment Market, Segmentation by Distribution Channel
The Global Hemorrhoids Treatment Market has been segmented by Distribution Channel into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies.
The global hemorrhoids treatment market segmentation by distribution channel encompasses various avenues through which products reach consumers. Pharmacies and drug stores constitute a significant distribution channel for hemorrhoids treatment products. These outlets offer over-the-counter medications and creams, providing convenience to consumers seeking immediate relief from symptoms such as itching and discomfort associated with hemorrhoids. With the accessibility of pharmacists for advice and recommendations, consumers can make informed choices about suitable treatments.
Online retail platforms have emerged as a burgeoning distribution channel for hemorrhoids treatment products. The convenience of online shopping allows consumers to discreetly purchase medications and remedies without the need for face-to-face interaction. Moreover, online platforms often offer a wide range of products, enabling consumers to compare options and select treatments that best suit their needs. The ease of access and availability of product information contribute to the growing popularity of online channels for purchasing hemorrhoids treatment products.
Medical institutions and hospitals represent another important distribution channel for hemorrhoids treatment products, particularly for prescription medications and surgical interventions. Healthcare professionals diagnose and prescribe appropriate treatments for hemorrhoids, which patients can obtain directly from hospital pharmacies or through affiliated healthcare providers. In cases where conservative measures fail to alleviate symptoms, patients may undergo procedures such as rubber band ligation or hemorrhoidectomy, which are typically performed in medical settings under the supervision of trained professionals. This distribution channel ensures that patients receive comprehensive care for managing hemorrhoids, ranging from pharmaceutical interventions to surgical solutions.
Global Hemorrhoids Treatment Market, Segmentation by Geography
In this report, the Global Hemorrhoids Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Hemorrhoids Treatment Market Share (%), by Geographical Region, 2024
The global hemorrhoids treatment market exhibits diverse trends across various geographical regions. In North America, the market is primarily driven by the high prevalence of hemorrhoids, sedentary lifestyles, and unhealthy dietary habits. Additionally, the presence of well-established healthcare infrastructure and a high level of awareness among the population contribute to the growth of the market in this region. The availability of advanced treatment options such as minimally invasive procedures and over-the-counter medications further boosts market growth.
In Europe, the hemorrhoids treatment market is characterized by a growing geriatric population and an increasing incidence of lifestyle-related diseases. The adoption of technologically advanced treatment modalities, coupled with the rising demand for minimally invasive procedures, drives market expansion in this region. Moreover, favorable reimbursement policies and government initiatives aimed at improving healthcare access play a significant role in augmenting market growth.
Asia Pacific represents a lucrative market for hemorrhoids treatment, attributed to factors such as the large population base, changing dietary patterns, and increasing awareness about available treatment options. The rise in disposable income levels and improving healthcare infrastructure further propel market growth in this region. Additionally, the presence of a vast pool of untreated patients and a growing focus on preventive healthcare measures create ample opportunities for market players to expand their presence in the Asia Pacific region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Hemorrhoids Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Aging Population Demographics
- Technological Advancements in Treatment Options
-
Rising Sedentary Lifestyles and Unhealthy Dietary Habits - The global hemorrhoids treatment market is witnessing a significant upsurge, attributed in part to the growing prevalence of sedentary lifestyles. With more individuals spending prolonged hours sitting, whether at work or during leisure, the incidence of hemorrhoids, a condition exacerbated by such habits, is on the rise. This sedentary behavior often leads to increased pressure on the veins in the rectal area, contributing to the development of hemorrhoids.
Unhealthy dietary habits further compound the issue, fueling the demand for effective treatment options. Diets lacking in fiber, coupled with inadequate hydration, can lead to constipation, a primary risk factor for hemorrhoids. The lack of fiber results in hard stools, which, when passed, can cause strain during bowel movements, aggravating hemorrhoidal symptoms. As a result, individuals are seeking various treatment modalities to alleviate discomfort and manage this prevalent condition effectively.
Restraints:
- Limited Awareness and Stigma Associated with Condition
- High Cost of Advanced Treatment Modalities
-
Stringent Regulatory Approval Processes - The global hemorrhoids treatment market is experiencing notable growth, yet it grapples with stringent regulatory approval processes. These processes often entail rigorous evaluation of safety and efficacy, leading to prolonged timelines for product clearance. Pharmaceutical companies investing in hemorrhoids treatments must navigate complex regulatory frameworks, including extensive clinical trials and documentation requirements. Such hurdles can delay market entry, impacting both revenue projections and patient access to innovative therapies.
Stringent regulatory scrutiny can foster a climate of risk aversion among manufacturers, deterring investment in research and development for hemorrhoids treatments. This could limit the emergence of novel therapies and innovative solutions in the market. Consequently, patients may face limited treatment options and prolonged reliance on conventional remedies, underscoring the critical need for streamlining regulatory pathways to accelerate the availability of safe and effective hemorrhoids treatments.
Opportunities:
- Emerging Markets with Untapped Potential
- Development of Minimally Invasive Procedures
-
Collaborative Efforts for Public Health Education - Collaborative efforts in the global hemorrhoids treatment market are increasingly focusing on public health education to raise awareness about prevention, management, and treatment options. Stakeholders across the healthcare spectrum, including pharmaceutical companies, healthcare providers, advocacy groups, and governmental organizations, are pooling resources to disseminate accurate information and debunk myths surrounding hemorrhoids. By leveraging various communication channels such as social media, educational campaigns, and community outreach programs, these collaborations aim to empower individuals with the knowledge needed to recognize early symptoms, adopt healthy lifestyle practices, and seek timely medical intervention.
These collaborative endeavors underscore the importance of destigmatizing discussions about hemorrhoids and promoting open dialogue between patients and healthcare professionals. By fostering a supportive environment, individuals are encouraged to seek help without hesitation, leading to earlier diagnosis and improved treatment outcomes. Moreover, public health education initiatives highlight the significance of incorporating dietary modifications, adequate hydration, and regular physical activity into daily routines to alleviate symptoms and prevent recurrence. Through these concerted efforts, the global community is striving to enhance public awareness, reduce the burden of hemorrhoidal disease, and ultimately improve the quality of life for affected individuals.
Competitive Landscape Analysis
Key players in Global Hemorrhoids Treatment Market include:
- Abbott Laboratories
- AstraZeneca Plc
- Bayer AG.
- Boehringer Ingelheim GmbH
- Boston Scientific Corporation
- CONMED Corporation
- Cook Medical
- GlaxoSmithKline
- Olympus Corporation.
- Pfizer Inc
- Takeda Pharmaceutical Company.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Administration Route
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Global Hemorrhoids Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population Demographics
- Technological Advancements in Treatment Options
- Rising Sedentary Lifestyles and Unhealthy Dietary Habits
- Restraints
- Limited Awareness and Stigma Associated with Condition
- High Cost of Advanced Treatment Modalities
- Stringent Regulatory Approval Processes
- Opportunities
- Emerging Markets with Untapped Potential
- Development of Minimally Invasive Procedures
- Collaborative Efforts for Public Health Education
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Hemorrhoids Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Drugs
- Laxatives
- NSAIDs
- Herbals
- Others
- Non-Surgical Procedures
- Drugs
- Global Hemorrhoids Treatment Market, By Administration Route, 2021 - 2031 (USD Million)
- Oral
- Topical
- Global Hemorrhoids Treatment Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Global Hemorrhoids Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Hemorrhoids Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbott Laboratories
- AstraZeneca Plc
- Bayer AG.
- Boehringer Ingelheim GmbH
- Boston Scientific Corporation
- CONMED Corporation
- Cook Medical
- GlaxoSmithKline
- Olympus Corporation.
- Pfizer Inc
- Takeda Pharmaceutical Company.
- Company Profiles
- Analyst Views
- Future Outlook of the Market